At least three vaccines are being funded, research being fast-tracked as the outbreak spreads faster than the response.
Prof Pontiano Kaleebu, the director of UVRI, says the infection with the Ebola Bundibugyo strain manifests almost the same ...
The ongoing Ebola virus outbreak in the Democratic Republic of Congo (DRC) and Uganda has now killed 61 people, with 359 ...
The 2026 outbreak of Ebola virus disease in DR Congo and Uganda, caused by Bundibugyo virus (Orthoebolavirus bundibugyoense), represents one of the most consequential epidemic emergencies in Africa.
SHELTON, CT / ACCESS Newswire / June 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing antiviral drugs that viruses cannot escape, NanoViricides ...
Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly ...
Akilimali has been helping in Ebola outbreak response efforts in Goma, a major metropolis in the eastern DRC. Flows of black ...
The vaccine development process and coordination between health organizations have improved since a devastating 2014-2016 ...
No approved therapeutics exist for the virus species causing the outbreak, which has been associated with more than 1,000 ...
Cases of the Andes virus have been rising in Argentina. Government-supported research is critical if we hope to address ...
The Centers for Research in Emerging Infectious Diseases were launched during the Covid-19 pandemic. The group lost its ...
On May 17, 2026, WHO determined the Ebola virus disease in the Democratic Republic of the Congo a Public Health Emergency of International Concern.1 Early data indicate two-thirds of cases have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results